Contact Us

Yes. FXYD6 rescue experiments in HCT 116 are well-suited for epithelial cross-validation: • Construct design: same considerations as FXYD6/HEK293 rescue — preserve membrane topology and FXYD motif. • Surface localization validation: confirm plasma membrane localization before functional assays. • Cross-background comparison: rescue in HCT 116 alongside HEK293 enables confirmation of context-independent FXYD6 functions. • Functional readout: rescue should restore Na⁺/K⁺-ATPase modulation in epithelial context. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying GSDMC (gasdermin C)'s role as a member of the gasdermin pyroptosis family or its emerging functions in cancer biology. The Knockout line is the standard tool for asking whether GSDMC is required for these processes — GSDMC is a less-characterized gasdermin family member with reported activation by caspase-8 in some tumor contexts, generating an N-terminal pore-forming fragment that drives pyroptosis. Overexpression is useful for studying GSDMC gain-of-function effects. For breast cancer pyroptosis research, the EDITGENE GSDMC Knockout in MCF-7 is highly relevant — MCF-7 is an ER+ luminal A breast cancer cell line, and GSDMC has been implicated in TNF-α-induced caspase-8-mediated pyroptosis in some breast cancer contexts. Rescue with wild-type or cleavage-resistant GSDMC enables structure-function studies. The knockout is valuable for studying GSDMC-mediated pyroptosis biology and emerging GSDMC-targeted approaches in breast cancer.

Yes. GSDMC rescue experiments require attention to gasdermin family architecture: • Construct design: use a codon-modified GSDMC sequence with a small C-terminal tag (FLAG, HA). GSDMC has N-terminal pore-forming domain and C-terminal auto-inhibitory domain — preserve all elements. • Cleavage-resistant rescue: putative caspase-8 cleavage site mutations enable studies of caspase-8-dependent activation. • N-terminal-fragment-only rescue: constitutive expression of GSDMC-N generates auto-induced pyroptosis. • Functional readout: rescue should restore TNF-α-induced caspase-8-mediated GSDMC cleavage and pyroptosis. MCF-7-specific considerations: • MCF-7 is a luminal A human breast cancer cell line (ER+, PR+, HER2-) — the most widely used breast cancer cell line for hormone-responsive cancer research. • Lentiviral transduction is supported with moderate efficiency. • ER+ status makes MCF-7 a relevant model for estrogen-responsive cancer biology.

The choice depends on whether you are studying GSDME (DFNA5, gasdermin E)'s role as a caspase-3-cleaved pyroptosis executor or modeling chemotherapy-induced pyroptosis in ovarian cancer. The Knockout line is the standard tool for asking whether GSDME is required for chemotherapy-induced pyroptosis — GSDME is cleaved by activated caspase-3 (downstream of intrinsic apoptosis), releasing the N-terminal pore-forming fragment that punctures the plasma membrane and converts apoptosis into pyroptosis; this 'apoptosis-to-pyroptosis switch' contributes to chemotherapy efficacy in GSDME-high tumors. Overexpression is useful for studying GSDME gain-of-function in cancer contexts. For ovarian cancer research, the EDITGENE GSDME Knockout in SK-OV-3 is highly relevant — SK-OV-3 is an ovarian adenocarcinoma cell line, and GSDME-driven pyroptosis is implicated in chemotherapy response. Rescue with wild-type, caspase-3-cleavage-resistant (D270A), or N-terminal-fragment-only GSDME enables structure-function studies. The knockout is valuable for studying chemotherapy-induced pyroptosis (cisplatin, paclitaxel) given GSDME's role in the apoptosis-pyroptosis switch — GSDME expression has been associated with cancer therapy response and immunogenic cell death.

Yes. GSDME rescue experiments are well-established for pyroptosis research: • Construct design: use a codon-modified GSDME sequence with a small C-terminal tag (FLAG, HA). GSDME has N-terminal pore-forming domain (GSDME-N) and C-terminal auto-inhibitory domain (GSDME-C) linked by a caspase-3 cleavage site (D270) — preserve all elements. • Caspase-3-cleavage-resistant rescue: D270A mutation abolishes caspase-3 cleavage, generating uncleavable GSDME that cannot drive apoptosis-to-pyroptosis switching. • N-terminal-fragment-only rescue: constitutive expression of GSDME-N (residues 1-270) generates auto-induced pyroptosis without requiring caspase activation. • Pore-forming-deficient rescue: GSDME-N membrane-binding residue mutations abolish pore formation. • Functional readout: rescue should restore chemotherapy-induced apoptosis-to-pyroptosis switching measured by LDH release and pyroptosis morphology. SK-OV-3-specific considerations: • SK-OV-3 is a human ovarian adenocarcinoma cell line (HER2-overexpressing, p53-null, TP53 mutant) — widely used in ovarian cancer research and chemotherapy response studies. • Lentiviral transduction is supported with moderate efficiency. • The HER2-overexpressing background makes SK-OV-3 relevant for studying HER2-driven cancer biology and trastuzumab response.

The choice depends on whether you are studying Gprc6a's role as a metabolic GPCR sensing basic L-amino acids, osteocalcin, and testosterone or its functions in liver metabolism, β-cell function, and male reproductive biology. The Knockout line is the standard tool for asking whether Gprc6a is required for these processes — Gprc6a is a class C GPCR (related to CaSR, mGluRs) with established roles in sensing extracellular L-arginine, L-lysine, L-ornithine, undercarboxylated osteocalcin (a bone-derived hormone), and reported as a non-classical testosterone receptor in some studies. Overexpression is useful for studying Gprc6a in heterologous expression contexts. For liver metabolism research, the EDITGENE Gprc6a Knockout in AML12 is highly relevant — AML12 is a non-tumorigenic mouse hepatocyte cell line providing a physiologically relevant context for studying hepatic Gprc6a function in glucose/lipid metabolism. Rescue with wild-type or signaling-deficient Gprc6a enables structure-function studies. The knockout is valuable for studying amino acid-induced hepatic signaling, osteocalcin-hepatocyte axis, and emerging Gprc6a-targeted metabolic disease therapeutics.

Yes. Gprc6a rescue experiments require attention to class C GPCR architecture: • Construct design: use a codon-modified Gprc6a sequence with a small intracellular C-terminal tag (FLAG, HA). Class C GPCRs have large extracellular Venus flytrap ligand-binding domain, cysteine-rich domain, and seven-transmembrane region — preserve all elements. • Signaling-deficient rescue: DRY motif or specific intracellular loop mutations disrupt G-protein coupling. • Surface localization validation: confirm plasma membrane localization by cell surface staining before functional assays. • Functional readout: rescue should restore basic L-amino acid-induced cellular signaling (Ca²⁺ mobilization, ERK activation) in hepatocyte context. AML12-specific considerations: • AML12 is a non-tumorigenic immortalized murine hepatocyte cell line (derived from TGF-α transgenic CD1 mouse liver) retaining hepatocyte differentiation features — the principal continuous mouse hepatocyte model for liver biology and metabolic research. • Lentiviral transduction is supported but may require optimization; characterize hepatocyte marker expression (albumin, transferrin) before phenotypic assays. • Specialized culture conditions are required (DMEM/F12 with insulin-transferrin-selenium-dexamethasone supplement).

The choice depends on whether you are studying GPER1 (GPR30, G protein-coupled estrogen receptor 1)'s role as a non-canonical estrogen-responsive membrane GPCR or its functions in pancreatic cancer biology. The Knockout line is the standard tool for asking whether GPER1 is required for non-genomic estrogen signaling — GPER1 is a seven-transmembrane GPCR activated by 17β-estradiol that initiates rapid non-genomic estrogen signaling (cAMP, ERK, EGFR transactivation) distinct from classical ESR1/ESR2 nuclear receptor signaling. Overexpression is useful for studying GPER1 in heterologous expression contexts. For pancreatic cancer research, the EDITGENE GPER1 Knockout in AsPC-1 is highly relevant — AsPC-1 is a pancreatic ductal adenocarcinoma cell line, and GPER1 has been implicated in pancreatic cancer biology with both pro- and anti-tumor effects reported. Rescue with wild-type or signaling-deficient GPER1 enables structure-function studies. The knockout is a critical specificity control for GPER1 agonist G-1 (LNS8801, in clinical development for various cancers), GPER1 antagonist G-15, and emerging GPER1-targeted cancer therapeutics.

Yes. GPER1 rescue experiments require attention to GPCR architecture: • Construct design: use a codon-modified GPER1 sequence with a small intracellular C-terminal tag (FLAG, HA). GPER1 is a seven-transmembrane GPCR — preserve estrogen-binding pocket and intracellular signaling regions. • Signaling-deficient rescue: DRY motif mutations disrupt G-protein coupling. • Surface localization validation: confirm plasma membrane localization by cell surface staining; GPER1 is partially intracellular in some contexts. • Functional readout: rescue should restore 17β-estradiol-induced cAMP elevation and rapid ERK activation. AsPC-1-specific considerations: • AsPC-1 is a human pancreatic ductal adenocarcinoma cell line (KRAS-mutant, derived from ascites of a patient with metastatic disease) — a relevant model for pancreatic cancer biology. • Lentiviral transduction is supported with moderate efficiency. • AsPC-1's metastatic origin and KRAS-mutant background make it valuable for pancreatic cancer mechanism studies.

The choice depends on whether you are studying FZD2 (Frizzled-2)'s role as a Wnt receptor or its functions in pancreatic cancer epithelial-mesenchymal transition (EMT) and metastasis. The Knockout line is the standard tool for asking whether FZD2 is required for these processes — FZD2 is one of ten Frizzled family Wnt receptors (FZD1-10) that, together with LRP5/6 co-receptors, transduce canonical Wnt signaling; FZD2 has emerged as particularly important in EMT-driven cancer progression and pancreatic cancer biology. Overexpression is useful for studying FZD2 gain-of-function effects. Important consideration: Frizzled family members share substantial Wnt ligand binding — single FZD2 knockout may show modest phenotypes if other Frizzleds compensate. Rescue with wild-type or Wnt-binding-deficient FZD2 is the standard specificity control. The knockout is valuable for studying pancreatic cancer EMT-driven progression, FZD2-targeted therapeutic antibodies (vantictumab is anti-FZD), and emerging Wnt pathway-targeted cancer drug development.

Yes. FZD2 rescue experiments require attention to seven-transmembrane GPCR architecture: • Construct design: use a codon-modified FZD2 sequence with a small intracellular C-terminal tag (FLAG, HA). FZD2 has extracellular cysteine-rich domain (CRD, Wnt binding), seven-transmembrane region, and intracellular tail — preserve all elements. • Wnt-binding-deficient rescue: CRD domain mutations abolish Wnt ligand binding. • Dishevelled-binding-deficient rescue: intracellular tail KTxxxW motif mutations disrupt DVL recruitment. • Functional readout: rescue should restore Wnt-induced TCF/LEF reporter activity and EMT-related phenotypes. PANC-1-specific considerations: • PANC-1 is a human pancreatic ductal adenocarcinoma cell line (KRAS G12D mutant, p53 mutant) — a relevant model for PDAC biology and Wnt pathway research in pancreatic cancer. • Lentiviral transduction is supported with moderate efficiency. • PANC-1's KRAS-mutant epithelial origin makes it complementary to AsPC-1 (KRAS-mutant ascites-derived) for pancreatic cancer studies.

The choice depends on whether you are studying FANCC's role as a core Fanconi anemia (FA) complex member or modeling Fanconi anemia complementation group C disease. The Knockout line is the standard tool for asking whether FANCC is required for these processes — FANCC is one of nine core FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, FANCT, plus FAAP-100 and FAAP-20) that form the FA core complex; this complex monoubiquitinates FANCD2 and FANCI in response to DNA interstrand crosslinks (ICLs), recruiting downstream FA-related proteins for ICL repair. Overexpression is useful for studying FANCC in heterologous expression contexts. For DNA repair and Fanconi anemia research, the EDITGENE FANCC Knockout in HAP1 is highly informative — FANCC mutations cause Fanconi anemia complementation group C (~10% FA cases), characterized by bone marrow failure, congenital abnormalities, and cancer predisposition. Rescue with wild-type or patient-derived mutant FANCC (e.g., IVS4+4 A>T splicing mutation common in Ashkenazi Jewish population) enables disease genotype-function studies. The knockout is valuable for studying interstrand crosslink repair, mitomycin C/cisplatin/cyclophosphamide sensitivity, and emerging FA-related cancer treatment strategies.

Yes. FANCC rescue experiments are well-established for FA pathway research: • Construct design: use a codon-modified FANCC sequence with a small C-terminal tag (FLAG, HA). FANCC interacts with FANCE in the FA core complex — preserve all elements. • FA mutation rescue: patient-derived FANCC mutations enable disease genotype-function studies — IVS4+4 A>T splicing mutation is common in Ashkenazi Jewish FA-C patients. • Complex assembly: rescue interpretation considers other FA core proteins (FANCA, FANCB, FANCE, FANCF, FANCG, FANCL, FANCM) expression. • Functional readout: rescue should restore FANCD2/FANCI monoubiquitination upon ICL stress and rescue mitomycin C/cisplatin sensitivity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying HDAC4's role as a class IIa HDAC or its functions in MEF2 co-repression and cardiac/skeletal muscle biology. The Knockout line is the standard tool for asking whether HDAC4 is required for these processes — HDAC4 is a class IIa HDAC that, like HDAC7, shuttles between nucleus and cytoplasm based on CaMK/PKD-mediated phosphorylation and 14-3-3 binding; HDAC4 represses MEF2-driven transcription in muscle, neurons, and other contexts. Overexpression is useful for studying HDAC4 gain-of-function effects. Important consideration: class IIa HDAC paralog (HDAC5, HDAC7, HDAC9) expression analysis aids interpretation. This product complements the parallel HDAC7 Knockout in HAP1 (also available) for class IIa HDAC family functional dissection. HDAC4 haploinsufficiency causes brachydactyly-mental retardation syndrome (BDMR). Rescue with wild-type or 14-3-3-binding-resistant HDAC4 enables structure-function studies.

Yes. HDAC4 rescue experiments require attention to class IIa architecture: • Construct design: use a codon-modified HDAC4 sequence with a small C-terminal tag (FLAG, HA). HDAC4 has the canonical class IIa architecture (N-terminal regulatory, central catalytic, C-terminal) — preserve all elements. • 14-3-3-binding-resistant rescue: S246A/S467A/S632A triple phospho-site mutations abolish 14-3-3-mediated cytoplasmic retention. • Catalytically-dead rescue: HDAC catalytic domain mutations abolish intrinsic deacetylase activity. • Functional readout: rescue should restore MEF2 co-repression activity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.